Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225)

This publication has 30 references indexed in Scilit:

• Contribution of the Kidneys but not Adrenal Glands to the Acute Antihypertensive Effects of Captopril in Spontaneously Hypertensive Rats
  Clinical Science, 1979
• Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients
  Annals of Internal Medicine, 1979
• EFFECTS OF CHRONIC TREATMENT WITH CAPTOPRIL(SQ 14,225), AN ORALLY ACTIVE INHIBITOR OFANGIOTENSIN I-CONVERTING ENZYME, INSPONTANEOUSLY HYPERTENSIVE RATS
  The Japanese Journal of Pharmacology, 1979
• Long-Term Efficacy of Captopril (SQ 14,225) In 2-Kidney Renal Hypertensive Rats
  Clinical and Experimental Hypertension, 1978
• Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients
  Progress in Cardiovascular Diseases, 1978
• Renin in the Spontaneously Hypertensive Rat
  Circulation Research, 1974
• Changes in plasma levels of vasopressin and renin in response to haemorrhage in dogs
  British Journal of Pharmacology, 1973
• Validation in awake rats of a tail-cuff method for measuring systolic pressure.
  Journal of Applied Physiology, 1973
• Blood Pressure Response and Antibody Formation in Spontaneously-Hypertensive Rats and Normal Albino Rats after Immunization against Angiotensin II*
  Endocrinology, 1972
• The Inability of Infusions of Angiotensin to Elevate the Plasma Vasopressin Concentration in the Anesthetized Dog
  Endocrinology, 1972